Premenstrual Syndrome Disease – Global Clinical Trials Review, H2, 2020

2020-11-10
Price :
Published : Nov-2020
No. of Pages : 131

Premenstrual Syndrome Disease – Global Clinical Trials Review, H2, 2020

Summary

GlobalData’s clinical trial report, “Premenstrual Syndrome Disease – Global Clinical Trials Review, H2, 2020” provides an overview of Premenstrual Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Premenstrual Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Beauty and Personal Care, Consumer Goods
Publisher : GlobalData
More Reports
Title Price Buy Now

Health and Beauty Retailing in France – Sector Overview, Market Size and Forecast to 2025

Health and Beauty Retailing in France - Sector Overview, Market Size and Forecast to 2025 Summary The research report provides both the historic and forecast market data of total retail sales, and the health and beauty market in France. It illustrates the data with charts, graphs and tables summarizing the value, with category details in health and beauty sector. The forecasts include the impact of COVID-19 on growth. The research report also reveals major retailers share in health and beauty sector with their price and market positioning in 2020. The report uses data from GlobalData's Retail database showing the trends in the market and sectors by value. It also reveals the major retailers by market share in 2020 in each of the sectors. All data includes the impact COVID-19 has had on ......
$995

Health and Beauty Retailing in Germany – Sector Overview, Market Size and Forecast to 2025

Health and Beauty Retailing in Germany - Sector Overview, Market Size and Forecast to 2025 Summary The research report provides both the historic and forecast market data of total retail sales, and the health and beauty market in Germany. It illustrates the data with charts, graphs and tables summarizing the value, with category details in health and beauty sector. The forecasts include the impact of COVID-19 on growth. The research report also reveals major retailers share in health and beauty sector with their price and market positioning in 2020. The report uses data from GlobalData's Retail database showing the trends in the market and sectors by value. It also reveals the major retailers by market share in 2020 in each of the sectors. All data includes the impact COVID-19 has had o......
$995

Health and Beauty Retailing in United States of America (USA) – Sector Overview, Market Size and Forecast to 2025

Health and Beauty Retailing in United States of America (USA) - Sector Overview, Market Size and Forecast to 2025 Summary The research report provides both the historic and forecast market data of total retail sales, and the health and beauty market in USA. It illustrates the data with charts, graphs and tables summarizing the value, with category details in health and beauty sector. The forecasts include the impact of COVID-19 on growth. The research report also reveals major retailers share in health and beauty sector with their price and market positioning in 2020. The report uses data from GlobalData's Retail database showing the trends in the market and sectors by value. It also reveals the major retailers by market share in 2020 in each of the sectors. All data includes the impact......
$995

Top Trends in Cosmetics and Toiletries, H2 2020 – Exploring the Latest Consumer and Innovation Trends

Top Trends in Cosmetics and Toiletries, H2 2020 - Exploring the Latest Consumer and Innovation Trends Summary This report outlines the key consumer and innovation trends impacting the cosmetics and toiletries industry in H2 2020. It explores market dynamics, industry deals, and news highlights, all of which are influencing innovation and purchasing decisions in the sector today. The performance of cosmetics and toiletries in the last quarter has been heavily shaped by COVID-19, as consumers spend more time indoors and social gatherings become less common. Brands are attempting to navigate decreased willingness to spend on non-essential categories by adapting their business models and developing suitable innovation where possible. Scope - Make-up, fragrances, and sun care are to see th......
$1450

Metrorrhagia (Abnormal Uterine Bleeding) Disease – Global Clinical Trials Review, H2, 2020

Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020 Summary GlobalData's clinical trial report, "Metrorrhagia (Abnormal Uterine Bleeding) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Metrorrhagia (Abnormal Uterine Bleeding) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metrorrhagia (Abnormal Uterine Bleeding). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData......
$2500

COVID-19 Impact on Shiseido, H2 2020 Update

COVID-19 Impact on Shiseido, H2 2020 Update Summary COVID-19 Impact on Shiseido, H2 2020 Update reports key findings as of 1st October, 2020 based on market analysis and brand diversification by industry and geography. Shiseido's low business diversification implies the company has limited resilience to the COVID-19 outbreak; however, its relatively low share of sales from highly affected regions gives it a slight geographic advantage over its peers. The company is expected to adopt a defensive stance to brace for the impact of the pandemic, and to take steps to expand its base in less affected markets in order to mitigate losses incurred during the pandemic. Scope - High dependency on the Asian market, particularly Japan, will affect overall sales of Shiseido. - A high concentration ......
$1450

COVID-19 Impact on Coty, H2 2020 Update

COVID-19 Impact on Coty, H2 2020 Update Summary COVID-19 Impact on Coty, H2 2020 Update key findings as of September 17th, 2020 based on market analysis and brand diversification by industry and geography. The companies in the beauty and fashion industry will experience a decline in overall sales due to the spread of coronavirus pandemic. Chanel, concentrating in single industry operations of cosmetics and toiletries, will be among the major companies to record a negative growth rate in 2020. Sectors such as fragrances and make-up do not feature in consumers' priority purchase list during this pandemic and so will be adversely impacted by the COVID-19 in 2020. Concurrently, sectors such as personal hygiene, male toiletries and skincare are expected to provide some resilience; however, t......
$1450

Supergoop! – Success Case Study

Supergoop! - Success Case Study Summary This report is part of GlobalData's Success and Failures case study series, which explores the reasons underpinning success or failure, and key learnings. It focuses on the success of Supergoop! a skincare brand that centers on incorporating SPF in personal care routines. This report focuses on the success of Supergoop! The brand is successful because it understands consumer behavior and attitudes towards sun care and designed a high quality product range that would appeal to all consumers during all seasons. Scope - The brand designed high quality products with transparent ingredients. - The products allowed for SPF to be easily integrated into a regular skin routine and to be reapplied throughout the day. - Sunergoop! is a mission-based brand,......
$995

COVID-19 Impact on Estee Lauder, H2 2020 Update

COVID-19 Impact on Estee Lauder, H2 2020 Update Summary COVID-19 Impact on Estee Lauder, H2 2020 Update reports key findings as of 4th September, 2020 based on market analysis and brand diversification by industry and geography. Overall, the C&T industry is facing a severe impact from the COVID-19 pandemic. Due to its lack of business diversity (coupled with relatively limited geographic diversification), Estée Lauder is in a difficult position. However, the recent announcement of its restructuring plan signifies its intentions to prepare itself to fight the current crisis and be ready for the post-COVID era. The recent shift towards digitalization and strengthening its online sales may prove beneficial for the company in the coming years. Scope - Estée Lauder's expansion in the per......
$1450

Opportunities in the Western Europe Cosmetics and Toiletries Industry

Opportunities in the Western Europe Cosmetics and Toiletries Industry Summary Western Europe cosmetics & toiletries industry was valued at US$95,989.2 million and is expected to reach US$ 1,10,073 million by 2024, registering a CAGR of 2.8%. In volume terms, the industry is expected to grow from 16,708.6 million units in 2019 to 17,379.1 million units in 2024, registering a CAGR of 0.8%. Western Europe had the highest per capita consumption and per capita expenditure of 39.3 units and US$226 in 2019. Based on the relative performance of countries on multiple metrics, Sweden, Demark, Austria, and Netherlands were shortlisted out of 19 countries as high-potential countries in Western Europe primarily due to the large cosmetics & toiletries industry size, projected high-value growth rates, ......
$2100
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy